Header Logo

Connection

Yuki Kageyama to Rituximab

Back to Details
This is a "connection" page, showing publications Yuki Kageyama has written about Rituximab.
Yuki Kageyama
Connection Strength
0.025
Rituximab
  1. [Development of syndrome of inappropriate secretion of ADH and reversible posterior leukoencephalopathy during initial rituximab-CHOP therapy in a patient with diffuse large B-cell lymphoma]. Rinsho Ketsueki. 2013 Mar; 54(3):269-72.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.